Desimone John Law Offices
Inotek Pharmaceuticals is a privately held biotechnology company based in Lexington, MA, dedicated to the discovery and development of innovative drugs targeting serious ocular diseases. The company's lead program, trabodenoson (INO-8875), is a selective adenosine mimetic designed to effectively reduce intraocular pressure associated with glaucoma and ocular hypertension.
With a robust pipeline of drug candidates addressing inflammation and oxidative stress, Inotek is focused on advancing its clinical programs toward commercialization. The experienced management team has a proven track record of successful New Drug Applications (NDAs), positioning Inotek to benefit patients and healthcare providers in the field of ophthalmology.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.
